What's Hot
View all perspectives
Dr. Laura Lewandowski LauraLewMad11
3 years 2 months ago
#ACR21
#SLE
SLE – Treatment: New Agents, Old Agents
Pooled data from 2 phase 3 trials (TULIP 1 and 2)
⏬LLDAS is an attainable T2T endpoint in adult SLE trials
⏬Anifrolumab treatment associated with earlier and more sustained LLDAS in adult SLE https://t.co/bxGlVsJOZC
Mike Putman EBRheum
3 years 2 months ago
1) Trial enrollees were likely partial/non responders to MMF at baseline (NIN had clean slate)
2) Unblinding from diarrhea from NIN, likely tilts toward NIN d/t PLBO effect
3) MMF-PLBO may have had dx longer than NIN-PLBO, missed critical early window to affect progression?
Mike Putman EBRheum
3 years 2 months ago
Interesting thoughts from Dr. Distler re:nintedanib & MMF in SSc-ILD
Agree we should look into MMF-nintedanib combo, but this graph makes me think MMF > NIN
Why would that be? Unlike NIN, MMF pts were NOT randomized, which likely favors NIN for a few (speculative) reasons: https://t.co/ZHBD8x74PM
American College of Rheumatology ACRheum
3 years 2 months ago
ACR Convergence 2021 attendees – join us this evening, Monday, Nov. 8, from 6:00 to 6:30 PM ET, for the virtual #ACR21 Tweet Up! Add to your agenda → https://t.co/lisFBp1scO #RheumTwitter https://t.co/3pO3quH2Sm
Max 🦖 MaxKonigMD
3 years 2 months ago
Hard to keep up with all the good news.
Congrats to @philseo, Program Director extraordinaire and Director of the Johns Hopkins Vasculitis Clinic, for receiving the ACR Distinguished Clinician Scholar Award.
#ACR21 @HopkinsMedicine @HopkinsMedNews https://t.co/FQb2W6KpYT
USSONAR USSONAR_Rh
3 years 2 months ago
8M415 Gout Imaging Advances: Ralf Thiele on US🔊and DECT
US>DECT: DECT needs a minimal density of MSU; DCS, tophi <2mm, liquid tophi may not be detected; US can show hyperemia
DECT>US: DECT can show areas that may be overlooked from standard protocols
💡Bonus:stay around for Q&A https://t.co/G7yQaj9fHw
Ashima Makol MD AshimaMakol
3 years 2 months ago
🔥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS & SENSCIS-ON(open-label ext)#ACR21 Dr Distler
✨MMF likely to stay 1st line, then Nintedanib
❓Is it time for MMF + Antifibrotic upfront??
Await SLS-III;Data so far seems supportive https://t.co/JWXMlsJgmc
Mike Putman EBRheum
3 years 2 months ago
Great Q&A re:VEXAS w/Marcela Ferrada
When to suspect VEXAS? Male, MCV >100, Plt <200
Can you order genetics yourself? No. 😆
Any IMT that works? Require high dose steroid, partial response to TCZ, needs close f/u d/t possible neutropenia!
How to refer to NIH? Slide!!! ⬇️⬇️ https://t.co/UvUCFbvX2r
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 2 months ago
Tribute #RheumPix to a special time in San Fran for ACR 2015 w/ my dear Father,Dr. Kamal M. El Ramahi, MD, FACR -may he Rest in Peace. I was an IM Res then not yet settled on a specialty when he sweetly invited me...the Rheum seed began its blossom
#ACR21
https://t.co/cp4eFCbTWl https://t.co/ayKAPi0WA2
CreakyJoints.org CreakyJoints
3 years 2 months ago
A study at #ACR21 by Charite-University Medicine Berlin researchers suggests taking tumor necrosis factor inhibitor (TNFi) #biologics earlier in the course of disease could slow down spinal progression in #AxialSpondyloarthritis patients. https://t.co/lDkaMkOcez
Steven Echard, CAE StevenEchard
3 years 2 months ago
#ACR21 - I don't remember the final count from ACR20, but 23k tweets🐦and 78.6 Million🔥 impressions have to be some type of record. @rheum_cat with over 1,600 tweets and counting. Don't forget the 𝐀𝐂𝐑𝟐𝟏 𝐓𝐰𝐞𝐞𝐭 𝐔𝐩 (𝟖𝐌𝟓𝟐𝟎) today at 6:00 PM. https://t.co/8qEMiorQCo
Alessia Alunno alessia_alunno
3 years 2 months ago
Join us now at the #ACR21 #COVID19 community hub to hear Kevin Winthrop and @RADoctor discussing about vaccines in patients with RMDs
#ACRAmbassador https://t.co/LivAoLu810
Aurelie Najm AurelieRheumo
3 years 2 months ago
Alcohol and MTX don't go along!
In a cohort of 1000+ early RA
Factors associated w/
1️⃣Nausea
Female OR 2
🍺 Alcohol OR 1.44
DAS28CRP OR 1.16
2️⃣Alopecia
Age OR 4.87
🍺 Alcohol OR 1.98
HAQ score OR 1.62
#Abst1444 #ACR21 @RheumNow https://t.co/zZG6aFR1SX
TheDaoIndex KDAO2011
3 years 2 months ago
👉HCQ dose < 400 mg/d are assc with SLE flare. Lower doses of HCQ may decrease risk of retinopathy. 👉For >80 kg (176 lbs), any dose < 400 mg/day is assc with increased odds of flare
(HCQ blood levels not measured)
Abst#1462 #ACR21 @rheumnow https://t.co/5tx3kruT8W
Jeffrey Sparks MD MMSc jeffsparks
3 years 2 months ago
I will be at the Early Career community Hub in 5 minutes (at 5pm Eastern) with @DanielHSolomon discussing "How to Get Published" #ACR21
Poster Hall